Performance Assessement for Paralympic Athletes (PARAPERF)
Evaluation of Performance in Paralympic Athletes: Performance Outcomes in Sports
The primary objective of the study: improvement of sportive performances by quantification and performances monitoring of paralympic athletes.
The secondary objectives of the study:
- quantification and performances monitoring of mechanical performances during the filed tests, the laboratory analysis and the sportive competitions;
- quantification and performances monitoring of physiological performances during the filed tests, the laboratory analysis and the sportive competitions;
- quantification and risk monitoring of discipline-relative musculo-squeletic troubles, caused by training or using of sportive equipment;
- quantification and mechanical monitoring by the made-to-measure or usual sportive material.
調査の概要
状態
状態
条件
条件
介入・治療
介入・治療
詳細な説明
研究の種類
研究の種類
入学 (予想される)
入学
段階
段階
- 適用できない
連絡先と場所
研究連絡先
研究連絡先
- 名前:Jean François Toussaint, MD, PhD
- 電話番号:+33 (0)1 42 34 82 10
- メール:jean-francois.toussaint@aphp.fr
研究連絡先のバックアップ
- 名前:François Genêt, MD, PhD
- 電話番号:+33 (0)1.47.10.70.68
- メール:francois.genet@aphp.fr
研究場所
-
-
-
Garches、フランス、92380
- 募集
- Service Médecine Physique et de Réadaptation, Hôpital Raymond Poincaré, APHP
-
-
参加基準
適格基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- High-lever paralympic athletes registered on the ministerial list or selected by Parasport Federation of France or Shooting Federation of France;
- Aged >= 14 years;
- Informed consent signed by adult athlete or by holder of parental authority or guardian for minor athlete;
- Covered by social security system.
Exclusion Criteria:
- Temporary or definitive contraindication to the practice of the affected sport activity;
- Undergoing anti-coagulated treatments;
- Cognitive disabilities conducting impossibility to participating to clinical trial, such as serious cognitive troubles, behaviors troubles, psychic troubles or upgraded curatorship needing;
- Under guardianship or judicial decision;
- Ongoing pregnancy.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:他の
- 割り当て:なし
- 介入モデル:単一グループの割り当て
- マスキング:なし(オープンラベル)
アーム数
武器と介入
参加者グループ / アーム参加者グループ / アーム |
介入・治療介入・治療 |
|---|---|
|
他の:Parasportives of various disciplines
|
Standardization of evaluation and clinical and sportive follow-up of athletes. Made-to-measure technical supports will be tested regarding the Paralympic regulations. |
この研究は何を測定していますか?
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Dynamic sportive activity
時間枠:through study completion, an average of 1 year
|
Dynamic sportive activity: Sprint Capacity Test will be used to have maximal speed.
|
through study completion, an average of 1 year
|
|
Dynamic sportive activity
時間枠:at 42 months
|
Dynamic sportive activity: Sprint Capacity Test will be used to have maximal speed.
|
at 42 months
|
|
Static sportive activity
時間枠:through study completion, an average of 1 year
|
Static sportive activity: maximal speed of movement of pression center.
|
through study completion, an average of 1 year
|
|
Static sportive activity
時間枠:at 42 months
|
Static sportive activity: maximal speed of movement of pression center.
|
at 42 months
|
二次結果の測定
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Biomechanical indices of performance: isometric power measurement
時間枠:through study completion, an average of 1 year
|
Isometric power will be measured by MicroFet & handgrip of 26 measures, advice for healthcare professionals to measure handgrip strength forces to test and document grip deficits and to evaluate consistency of effort.
|
through study completion, an average of 1 year
|
|
Biomechanical indices of performance: arms and shoulder's Strength
時間枠:through study completion, an average of 1 year
|
Arms and shoulder's Strength will be measured by force platform.
|
through study completion, an average of 1 year
|
|
Physiological indices of performance: maximal aerobic speed (MAS)
時間枠:Twice through study completion, an average of 42 months
|
Maximal aerobic speed (MAS) will be measured by Repetition Per Minute on a Arm ergometer.
|
Twice through study completion, an average of 42 months
|
|
Physiological indices of performance: maximal aerobic power
時間枠:Twice through study completion, an average of 42 months
|
Maximal aerobic power will be measured by following Watts fluctuation during the incremental hand-biking test.
|
Twice through study completion, an average of 42 months
|
|
Fatigue assessment
時間枠:Twice through study completion, an average of 42 months
|
Fatigue assessment will be measured by Fatigue Index (Power max ratio).
|
Twice through study completion, an average of 42 months
|
|
Blood lactate concentration
時間枠:immediately after the intervention
|
Blood lactatemia level will be measured by lactometer.
|
immediately after the intervention
|
|
VO2 peak oxygen uptake
時間枠:through study completion, an average of 1 year
|
VO2 peak oxygen uptake
|
through study completion, an average of 1 year
|
|
Peak breath expiration volume assessment
時間枠:through study completion, an average of 1 year
|
VE peak: peak breath expiration volume
|
through study completion, an average of 1 year
|
|
Peak cardiac frequence
時間枠:through study completion, an average of 1 year
|
CF: peak cardiac frequence
|
through study completion, an average of 1 year
|
|
Musculo-squeletic troubles risks measurement
時間枠:through study completion, an average of 1 year
|
Musculo-squeletic troubles risks will be measured by medical following and clinical method of functional assessment of the shoulder (i.e.
"Constant scale").
|
through study completion, an average of 1 year
|
|
Time and distance of deceleration of wheelchair during riding test
時間枠:through study completion, an average of 1 year
|
Time and distance of deceleration of wheelchair during riding test: measured by signal analysis of instrumented wheelchair (inertial control units).
|
through study completion, an average of 1 year
|
|
Mechanical indices of wheelchair propulsion - applied forces on handrim during the propulsion
時間枠:through study completion, an average of 1 year
|
Applied forces on handrim during the propulsion: measured by force platform.
|
through study completion, an average of 1 year
|
|
Acceleration profil during the propulsion
時間枠:through study completion, an average of 1 year
|
through study completion, an average of 1 year
|
|
|
Speed profil during the propulsion
時間枠:through study completion, an average of 1 year
|
through study completion, an average of 1 year
|
協力者と研究者
捜査官
捜査官
- 主任研究者:François Genêt, MD, PhD、Service Médecine Physique et de Réadaptation, Hôpital Raymond Poincaré, APHP
- スタディディレクター:Jean François Toussaint, MD, PhD、Centre d'Investigation en Médecine du Sport, Hôpital Hôtel Dieu, APHP
研究記録日
主要日程の研究
研究開始 (実際)
研究開始
一次修了 (予想される)
一次修了
研究の完了 (予想される)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (実際)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
本研究に関する用語
キーワード
その他の研究ID番号
その他の研究ID番号
- APHP201139
- 2020-A02919-30 (レジストリ識別子:IDRCB)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。